# US 2012/0252808 A1 · Quinoline amide m1 receptor positive allosteric modulators

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252808 A1
- Document ID: US20120252808A1
- Status: Published application
- Kind: A1
- Application number: 13/515,724
- Filed: 2010-12-13
- Published: 2012-10-04
- Earliest claimed: 2009-12-17
- Assignees: Merck Sharp & Dohme Corp.
- Inventors: Scott D. Kuduk; Kelly-Ann S. Schlegel; Zhi-Qiang Yang
- Web page: https://patentgrep.com/patent/US20120252808A1

## CPC

- C07D 215/60: N-oxides
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/04: Centrally acting analgesics, e.g. opioids
- A61P 25/18: Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A61P 25/20: Hypnotics; Sedatives
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 215/48: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D 401/04: directly linked by a ring-member-to-ring-member bond
- C07D 401/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 401/10: linked by a carbon chain containing aromatic rings
- C07D 401/14: containing three or more hetero rings
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07D 405/14: containing three or more hetero rings
- C07D 409/14: containing three or more hetero rings
- C07D 413/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 413/10: linked by a carbon chain containing aromatic rings
- C07D 413/14: containing three or more hetero rings
- C07D 417/10: linked by a carbon chain containing aromatic rings
- C07D 417/14: containing three or more hetero rings
- C07D 471/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention is directed to quinoline amide compounds of formula (I) which are M1 receptor positive allosteric modulators and that are useful in the treatment of diseases in which the M1 receptor is involved, such as Alzheimer's disease, schizophrenia, pain or sleep disorders. The invention is also directed to pharmaceutical compositions comprising the compounds, and to the use of the compounds and compositions in the treatment of diseases mediated by the M1 receptor.

## Claims

### Claim 1

A compound of formula (I):
wherein
X1 is selected from the group consisting of
(1) N, and
(2) N→O;
X2-X3 is selected from the group consisting of
(1) —CH2—CH2—,
(2) —O—CH2—,
(3) —CH2—O—, or
(4) —CH2—;
X4, X5, X6 and X7 are each selected from the group consisting of
(1) N,
(2) N→O,
(3) CH,
(4) O
provided that one of X4, X5, X6 and X7 may be absent, thereby forming a five-membered ring;
R1 is selected from the group consisting of
(1) hydrogen,
(2) halogen,
(3) —C1-6 alkyl,
(4) —C2-6 alkynyl,
(4) phenyl,
(5) ═O,
(6) ═CH2,
(7) hydroxyl,
wherein the R1 alkyl, alkynyl or phenyl group is optionally substituted with one or more
(a) hydroxyl, or
(b) halogen;
R2A and R2B are independently selected from the group consisting of
(1) hydrogen,
(2) hydroxyl, and
(3) halogen,
or R2A and R2B together form ═O;
R3 is optionally present at one or more of the ring carbon atoms, and is independently selected from the group consisting of
(1) halogen,
(2) —O—C1-6 alkyl,
(3) —S—C1-6 alkyl, or
(4) a heteroaryl group, which is an aromatic cyclic group, having from five to twelve ring atoms, said ring atoms selected from C, O, N, N→O or S, at least one of which is O, N, N→O or S, wherein the heteroaryl is optionally substituted with C1-6 alkyl;
R4 is optionally present at one or more of the ring atoms, and is selected from the group consisting of
(1) hydroxyl,
(2) halogen,
(3) —C1-6 alkyl,
(4) —O—C1-6 alkyl,
(5) —S—C1-6 alkyl,
(6) —C3-8 cycloalkyl,
(7) —C6-10 aryl,
(8) —CN,
(9) a heteroaryl group, which is an aromatic cyclic group, having from five to twelve ring atoms, said ring atoms selected from C, O, N, N→O or S, at least one of which is O, N, N→O or S,
(10) —O-heterocyclyl,
(11) —NRARB,
wherein RA and RB are selected from the group consisting of
(a) hydrogen, or
(b) —C1-6 alkyl,
or RA and RB are linked together with the nitrogen to which they are attached to form a 4-6 membered carbocyclic ring, wherein one or two of the ring carbon atoms is optionally replaced by a nitrogen, oxygen or sulfur, and the ring is optionally substituted with one or more
(a) halogen,
(b) hydroxyl,
(c) C1-6 alkyl,
(d) —O—C1-6 alkyl,
(e) —C1-6 alkyl;
wherein n is 0-1; and the alkyl, cycloalkyl, aryl or heteroaryl R4 group is optionally substituted with one or more
(a) halogen,
(b) hydroxy,
(c) —O—C1-6 alkyl,
(d) —C1-6 alkyl,
(e) —S—C1-6 alkyl, or
(f) a heteroaryl group, which is an aromatic cyclic group, having from five to twelve ring atoms, said ring atoms selected from C, O, N, N→O or S, at least one of which is O, N, N→O or S,
wherein the alkyl, aryl or heteroaryl moiety is optionally substituted with one or more
(i) halogen,
(ii) hydroxy,
(iii) —O—C1-6 alkyl, or
(iv) —C1-6 alkyl;
or two R4 groups are linked together to form a three or four atom fused ring heteroaryl group, said ring atoms selected from C, O, N, N→O or S, at least one of which is O, N, N→O or S,
or a pharmaceutically acceptable salt thereof.

### Claim 2 (depends on 1)

A compound of claim 1, or a pharmaceutically acceptable salt thereof, wherein one or two of X4, X5, X6 and X7 is N or N→O and the others are each CH or C substituted with R4.

### Claim 3 (depends on 1)

A compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein X1 is N.

### Claim 4 (depends on 1)

A compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein X2-X3 is —CH2—CH2—, —O—CH2— or —CH2—O—.

### Claim 5 (depends on 1)

A compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein X4 is N and X5, X6 and X7 are each CH, or X4, X6 and X7 are each CH and X5 is N, or X4 and X6 are each N, X7 is CH, and X5 is C substituted with R4.

### Claim 6 (depends on 1)

A compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein R1 is halogen.

### Claim 7 (depends on 1)

A compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein R2A and R2B are each hydrogen, or R2A is hydrogen and R2B is halogen.

### Claim 8 (depends on 1)

A compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein R3A and R3B are each hydrogen, or R3A is halogen and R3B is hydrogen.

### Claim 9 (depends on 1)

A compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein each of R2A, R2B, R3A and R3B is hydrogen.

### Claim 10 (depends on 1)

A compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein R4 is present at one of the ring atoms, and is selected from the group consisting of
(1) halogen,
(2) —C1-6 alkyl, or
(3) a heteroaryl group, which is an aromatic cyclic group, having from five to twelve ring atoms, said ring atoms selected from C, O, N, N→O or S, at least one of which is O, N, N→O or S,
wherein said alkyl or heteroaryl R4 group is optionally substituted with one or more
(a) halogen,
(b) hydroxy,
(c) —O—C1-6 alkyl,
(d) —C1-6 alkyl, optionally substituted with halogen, or
(e) —S—C1-6 alkyl.

### Claim 11 (depends on 1)

A compound claim 1, in which the compound of formula (I) is a compound of formula (II):
or a pharmaceutically acceptable salt thereof, wherein X2, X3, R1, R2A, R2B, R3A, R3B and R4 are as defined in claim 1.

### Claim 12 (depends on 11)

A compound of claim 11, or a pharmaceutically acceptable salt thereof, wherein X2-X3 is —CH2—CH2— —O—CH2— or —CH2—O—.

### Claim 13 (depends on 11)

A compound of claim 11 or a pharmaceutically acceptable salt thereof, wherein R1 is halogen.

### Claim 14 (depends on 11)

A compound of claim 11 or a pharmaceutically acceptable salt thereof, wherein R2A and R2B are each hydrogen, or R2A is hydrogen and R2B is halogen.

### Claim 15 (depends on 11)

A compound of claim 11 or a pharmaceutically acceptable salt thereof, wherein R4 is selected from the group consisting of
(1) a heteroaryl group, which is an aromatic cyclic group, having from five to twelve ring atoms, said ring atoms selected from C, O, N or S, at least one of which is O, N or S,
(2) halogen,
(3) hydroxy,
(4) —O—C1-6 alkyl,
(5) —C1-6 alkyl, or
(6) —S—C1-6 alkyl,
wherein said alkyl or heteroaryl R4 moiety is optionally substituted with one or more
(a) halogen,
(b) hydroxy,
(c) —O—C1-6 alkyl,
(d) —C1-6 alkyl, optionally substituted with halogen, or
(e) —S—C1-6 alkyl.

### Claim 16 (depends on 1)

A compound of claim 1, in which the compound of formula (I) is a compound of formula (III):
or a pharmaceutically acceptable salt thereof, wherein X2, X3, R1, R2A, R2B, R3A, R3B, and R4 are as described above.

### Claim 17 (depends on 16)

A compound of claim 16, or a pharmaceutically acceptable salt thereof, wherein X2-X3 is —CH2—CH2—, —O—CH2— or —CH2—O—.

### Claim 18 (depends on 1)

A compound of claim 1, which is selected from the group consisting of:
4-[(6-Chloropyridin-3-yl)methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-Hydroxycyclohexyl]-4-[(6-methylpyridin-3-yl)methyl]quinoline-2-carboxamide;
4-[(6-Chloropyridin-3-yl)methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide 1 oxide;
4-[(6-Cyclopropylpyridin-3-yl)methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-Hydroxycyclohexyl]-4-{[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-Hydroxycyclohexyl]-4-(pyridin-3-ylmethyl)quinoline-2-carboxamide;
N-[(1S,2S)-2-Hydroxycyclohexyl]-4-{[6-(methylsulfanyl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-Hydroxycyclohexyl]-4-{[6-(1-methyl-1H-pyrazol-4-yl)-1-oxidopyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-Fluorocyclohexyl]-4-{[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(3S,4S)-4-Hydroxytetrahydro-2H-pyran-3-yl]-4-{[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-4-[(6-methoxypyridin-3-yl)methyl]quinoline-2-carboxamide;
4-[(6-Ethoxypyridin-3-yl)methyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-4-[(2-methoxypyridin-4-yl)methyl]quinoline-2-carboxamide;
N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-4-{[2-(methylsulfanyl)pyrimidin-5-yl]methyl}quinoline-2-carboxamide;
4-[Fluoro(6-methoxypyridin-3-yl)methyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide hydrate;
4-[(6-Chloropyridin-3-yl)methyl]-8-fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
4-{[6-(Difluoromethyl)pyridin-3-yl]methyl}-8-fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
4-[Fluoro(6-methoxypyridin-3-yl)methyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-8-methoxyquinoline-2-carboxamide;
8-Fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(6-methoxypyridin-3-yl)methyl]quinoline-2-carboxamide;
8-Fluoro-4-[(6-hydroxypyridin-3-yl)methyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
8-Fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(6-methoxy-1-oxidopyridin-3-yl)methyl]quinoline-2-carboxamide;
8-Fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(2-methoxypyridin-4-yl)methyl]quinoline-2-carboxamide;
8-Fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(2-methoxy-1-oxidopyridin-4-yl)methyl]quinoline-2-carboxamide;
5,8-Difluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(6-methoxypyridin-3-yl)methyl]quinoline-2-carboxamide;
4-[(6-chloropyridin-3-yl)methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[(6-methylpyridin-3-yl)methyl]quinoline-2-carboxamide;
4-[(6-chloropyridin-3-yl)methyl]-N-[(1R,2R)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
4-[(6-chloropyridin-3-yl)methyl]-N-(tetrahydro-2H-pyran-3-yl)quinoline-2-carboxamide,
4-[(6-chloropyridin-3-yl)methyl]-N-[(1S,2R)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
4-[(6-chloropyridin-3-yl)methyl]-N-(tetrahydro-2H-pyran-4-yl)quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-(4-methoxybenzyl)quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-(4-methoxybenzyl)quinoline-2-carboxamide 1-oxide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
4-({6-[(6-chloropyridin-3-yl)methyl]pyridin-3-yl}methyl)-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-(pyridin-3-ylmethyl)quinoline-2-carboxamide;
1,5-anhydro-3-[((4-[(6-chloropyridin-3 quinolin-2-yl]carbonyl)amino]-2,3-dideoxy-L-threo-pentitol;
4-[(6-chloropyridin-3-yl) methyl]-N-[(1S,2S)-2-(hydroxymethyl)cyclohexyl]quinoline-2-carboxamide;
4-[(6-cyclopropylpyridin-3-yl)methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]quino line-2-carboxamide;
4-[(6-chloropyridin-3-yl)methyl]-N-[(1S,2S)-2-fluorocyclohexyl]quinoline-2-carboxamide;
4-[(6-ethylpyridin-3-yl)methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[(6′-methyl-2,3′-bipyridin-5-yl)methyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(morpholin-4-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-(pyridin-4-ylmethyl)quinoline-2-carboxamide;
4-[(6-cyanopyridin-3-yl)methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[4-(1H-pyrazol-1-yl)benzyl]quinoline-2-carboxamide;
4-[(3,5-dimethylisoxazol-4-yl)methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
4-[(6′-fluoro-2,3′-bipyridin-5-yl)methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
4-[(5′-fluoro-2,3′-bipyridin-5-yl)methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
4-{[6-(3,5-dimethylisoxazol-4-yl)pyridin-3-yl]methyl}-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(thiophen-3-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(pyrazin-2-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(1,3-thiazol-5-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(1,3-oxazol-2-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(1H-pyrazol-1-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(trifluoromethyl)pyridin-3-yl]methyl}quino line-2-carboxamide;
4-[(6-fluoropyridin-3-yl)methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
4-[(6-chloropyridin-3-yl)methyl]-8-fluoro-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
4-(4-cyanobenzyl)-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(1-methyl-1H-pyrazol-5-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(pyrimidin-5-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(2-methoxypyrimidin-5-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[4-(1H-1,2,4-triazol-1-yl)benzyl]quinoline-2-carboxamide;
4-(4-chlorobenzyl)-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
4-(4-chlorobenzyl)-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
4-[(6-chloropyridin-3-yl)methyl]-5,8-difluoro-N-[(1S,2S)-2-hydroxycyclohexyl]quino line-2-carboxamide;
4-[(6-chloropyridin-3-yl)methyl]-8-fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
4-(4-chlorobenzyl)-8-fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-([6-(pyrimidin-2-yl)pyridin-3-yl]methyl quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(pyridazin-4-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(3-methoxypyrazin-2-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(1,3-thiazol-4-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[(6′-methoxy-2,3′-bipyridin-5-yl)methyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[(2′-methoxy-2,3′-bipyridin-5-yl)methyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[(5′-methoxy-2,3′-bipyridin-5-yl)methyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(1-methyl-1,4-imidazol-2-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(1-methyl-1H-imidazol-2-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[(4′-methoxy-2,3′-bipyridin-5-yl)methyl]quinoline-2-carboxamide;
4-[(6-chloropyridin-3-yl)methyl]-5,8-difluoro-N-[(3 R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
4-(4-chlorobenzyl)-5,8-difluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(methylsulfanyl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[(6-methoxypyridin-3-yl)methyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(1,3-thiazol-2-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
4-[(6-chloropyridin-3-yl)methyl]-7,8-difluoro-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
4-[(6-chloropyridin-3-yl)methyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-8-(methylsulfanyl)quinoline-2-carboxamide;
N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[4-(1-methyl-1H-pyrazol-4-yl)benzyl]quinoline-2-carboxamide;
N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[4-(1-methyl-1H-pyrazol-5-yl)benzyl]quinoline-2-carboxamide;
N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(6-methoxypyridin-3-yl)methyl]quinoline-2-carboxamide;
N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(6-methoxypyridin-3-yl)methyl]quinoline-2-carboxamide;
N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[4-(1H-pyrazol-1-yl)benzyl]quino line-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[(1-methyl-1H-benzotriazol-5-yl)methyl]quinoline-2-carboxamide;
4-[(6-chloropyridin-3-yl)methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide 1-oxide;
4-(4-chlorobenzyl)-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide 1-oxide;
4-(4-cyanobenzyl)-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-(imidazo[1,2-a]pyridin-6-ylmethyl)quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-([1,2,4]triazolo[1,5-a]pyridin-6-ylmethyl)quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[(5-methoxypyridin-3-yl)methyl]quinoline-2-carboxamide;
4-[fluoro(6-methoxypyridin-3-yl)methyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-8-methoxyquinoline-2-carboxamide;
4-(3,4-difluorobenzyl)-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
4-(4-chloro-3-fluorobenzyl)-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
8-fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(6-methoxypyridin-3-yl)methyl]quinoline-2-carboxamide;
N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-{[6-(trifluoromethyl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[4-(2-methyl-1,3-thiazol-4-yl)benzyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[4-(3-methyl-1,2,4-oxadiazol-5-yl)benzyl]quinoline-2-carboxamide;
8-fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[4-(1-methyl-1H-pyrazol-4-yl)benzyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[4-(pyrimidin-2-yl)benzyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[4-(1-methyl-1H-pyrazol-3-yl)benzyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[4-(1,3-thiazol-2-yl)benzyl]quinoline-2-carboxamide;
4-[(4-chlorophenyl)(fluoro)methyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-(4-methoxybenzyl)-8-(1-methyl-1H-pyrazol-4-yl)quinoline-2-carboxamide;
4-[(6-chloropyridin-3-yl)methyl]-N-[(1S,2R)-2-hydroxycyclopentyl]quinoline-2-carboxamide;
4-[(6-chloropyridin-3-yl)methyl]-N-[(1S,2S)-2-hydroxycyclopentyl]quinoline-2-carboxamide;
4-[fluoro(6-methoxypyridin-3-yl)methyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
8-chloro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(6-methoxypyridin-3-yl)methyl]quinoline-2-carboxamide;
8-fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-{[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(3S,4S)-4-hydroxytetrahydro-2H-pyran-3-yl]-4-[(6-methoxypyridin-3-yl)methyl]quinoline-2-carboxamide;
4-[(6-chloropyridin-3-yl)methyl]-8-fluoro-N-[(3S,4S)-4-hydroxytetrahydro-2H-pyran-3-yl]quinoline-2-carboxamide;
N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-{[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(3S,4S)-4-hydroxytetrahydro-2H-pyran-3-yl]-4-[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
8-chloro-4-[(2-chloropyridin-4-yl)methyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
4-{[6-(3-chloro-1-methyl-1H-pyrazol-4-yl)pyridin-3-yl}methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
8-chloro-N-[(1S,2S)-2-hydroxycyclohexyl]-4-[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
4-[(2-chloropyridin-4-yl)methyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
4-[(2-chloropyridin-4-yl)carbonyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[6-(1-methyl-1H-pyrazol-4-yl)-1-oxidopyridin-3-yl]methyl}quinoline-2-carboxamide;
4-[(2-chloropyridin-4-yl)methyl]-N-[(3S,4S)-4-hydroxytetrahydro-2H-pyran-3-yl]quinoline-2-carboxamide;
N-[(3S,4S)-4-hydroxyheptan-3-yl]-4-{[2-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yl]methyl}quinoline-2-carboxamide;
8-fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(6-methylpyridin-3-yl)methyl]quinoline-2-carboxamide;
4-[(6-chloropyridin-3-yl)methyl]-N-cyclohexylquinoline-2-carboxamide;
4-[(2-chloropyridin-4-yl)methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]quinoline-2-carboxamide;
5,8-difluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(6-methoxypyridin-3-yl)methyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[(2-methylpyridin-4-yl)methyl]quinoline-2-carboxamide;
N-[(3S,4S)-4-hydroxyheptan-3-yl]-4-{[2-(1-methyl-1H-1-pyrazol-4-yl)pyridin-4-yl]methyl}quinoline-2-carboxamide;
5,8-difluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-{[6-(trifluoromethyl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-(pyrazin-2-ylmethyl)quinoline-2-carboxamide;
N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-(pyrazin-2-ylmethyl)quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[(2-methoxypyridin-4-yl)methyl]quinoline-2-carboxamide;
N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(2-methoxypyridin-4-yl)methyl]quino line-2-carboxamide;
4-{[6-(difluoromethyl)pyridin-3-yl]methyl}-8-fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
8-fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(6-methoxy-1-oxidopyridin-3-yl)methyl]quinoline-2-carboxamide;
4-[(2-chloropyridin-4-yl)methyl]-8-fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(2-methylpyridin-4-yl)methyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-fluorocyclohexyl]-4-{[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(1S,2S)-2-hydroxycyclohexyl]-4-{[2-(methylsulfanyl)pyrimidin-5-yl]methyl}quino line-2-carboxamide;
4-[(6-chloropyridin-3-yl)methyl]-N-[(1S)-2-oxocyclohexyl]quinoline-2-carboxamide;
8-fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(2-methoxypyridin-4-yl)methyl]quinoline-2-carboxamide;
N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-{[2-(methylsulfanyl)pyrimidin-5-yl]methyl}quinoline-2-carboxamide;
8-fluoro-4-[(6-hydroxypyridin-3-yl)methyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
4-[(6-hydroxypyridin-3-yl)methyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
4-[(2-hydroxypyridin-4-yl)methyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
N-(2-methylcyclohexyl)-4-{[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
8-fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(2-methoxy-1-oxidopyridin-4-yl)methyl]quino line-2-carboxamide;
8-fluoro-4-[(2-hydroxypyridin-4-yl)methyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H=pyridin-4-yl]quinoline-2-carboxamide;
4-{[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]methyl}-N-[(1R,2S)-2-phenylcyclohexyl]quinoline-2-carboxamide;
N-[(1R,2R)-2-ethynylcyclohexyl]-4-{[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
5,8-difluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(2-methoxypyridin-4-yl)methyl]quinoline-2-carboxamide;
N-[(1S,2S)-2-(hydroxymethyl)cyclohexyl]-4-{[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
4-[(6-ethoxypyridin-3-yl)methyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-{[6-(2,2,2-trifluoroethoxy)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-{[6-(tetrahydro-2H-pyran-4-yloxy)pyridin-3-yl]methyl}quino line-2-carboxamide;
N-(2-methylidenecyclohexyl)-4-{[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-[(6-methoxy-1-oxidopyridin-3-yl)methyl]quinoline-2-carboxamide;
4-[(2-ethoxypyridin-4-yl)methyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
8-fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-{[6-(2,2,2-trifluoroethoxy)pyridin-3-yl]methyl}quinoline-2-carboxamide;
4-[(6-fluoropyridin-3-yl)methyl]-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-{[6-(methylsulfanyl)pyridin-3-yl]methyl}quinoline-2-carboxamide;
4-[(2-ethoxypyridin-4-yl)methyl]-8-fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
4-[(6-ethoxypyridin-3-yl)methyl]-8-fluoro-N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]quinoline-2-carboxamide;
N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-4-{[2-(methylsulfanyl)pyridin-4-yl]methyl}quinoline-2-carboxamide;
or a pharmaceutically acceptable salts thereof.

### Claim 19 (depends on 1)

A pharmaceutical composition comprising a therapeutically effective amount of a compound of claim 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

### Claim 20 (depends on 1)

A pharmaceutical composition for the treatment of a disease or disorder mediated by the muscarinic M1 receptor, wherein said disease or disorder is selected from the group consisting of Alzheimer's disease, schizophrenia, pain or sleep disorders, comprising a therapeutically effective amount of a compound of claim 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

### Claim 21 (depends on 20)

Use of a pharmaceutical composition of claim 20 for the treatment of a disease or disorder mediated by the muscarinic M1 receptor, wherein said disease or disorder is selected from the group consisting of Alzheimer's disease, schizophrenia, pain or sleep disorders.

### Claim 22 (depends on 1)

Use of a compound of claim 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, for the manufacture of a medicament for the treatment of a disease or disorder mediated by the muscarinic M1 receptor, wherein said disease or disorder is selected from the group consisting of Alzheimer's disease, schizophrenia, pain or sleep disorders.

### Claim 23 (depends on 1)

A method of treating a disease or disorder mediated by the muscarinic M1 receptor, wherein said disease or disorder is selected from the group consisting of Alzheimer's disease, schizophrenia, pain or sleep disorders in a patient in need thereof; comprising administering to the patient a therapeutically effective amount of a compound of claim 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
